Free Trial

Amgen launches $5B 5-parter Date $MM.......>

PIPELINE
PIPELINE: Amgen launches $5B 5-parter
Date $MM Issuer/Rating/Desc/Maturity/Yld; Priced *; Launch #
02/18 $5B #Amgen 5-part: $500M 5Y +55, $750M 7Y +75, $1.25B@: 10Y +90, 20Y +117,
30Y +137
02/18 $2B #Gazprom 10Y 3.25%
02/18 $1.75B #BNP Paribas Perp NC10 4.5%
02/18 $1.75B #FirstEnergy $300M 5Y +70, $600M 10Y +110, $850M 30Y +140
02/18 $500M #KKR Group Finance 30Y +165
02/18 $1B Commonwealth Edison, 10Y +70a, 30Y +105a
02/18 $600M Brookfield Finance 30Y +150a
02/18 $300M Forestar Group 8NC3
02/18 $Benchmark Mizuho Fncl 4.25NC3.25 +65a, 6.25NC5.25 +85a, 11.25NC10.25
+105a
02/18 $Benchmark MUFG (Mitsubishi UFJ Financial Group) 5Y +80a, 10Y +100a
02/18 $Benchmark Republic Services 10Y +80a, 30Y +110a
02/18 $Benchmark National Retail 10Y +100a, 30Y +120a

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.